| 28 Sept 2012 | OTHER | PAR PHARMACEUTICAL COMPANIES, INC. | 4,000 | 50.00 USD | |
| 28 Sept 2012 | OTHER | PAR PHARMACEUTICAL COMPANIES, INC. | 1,980 | 50.00 USD | deriv |
| 28 Sept 2012 | OTHER | PAR PHARMACEUTICAL COMPANIES, INC. | 30,090 | 50.00 USD | deriv |
| 28 Sept 2012 | OTHER | PAR PHARMACEUTICAL COMPANIES, INC. | 10,000 | 18.30 USD | deriv |
| 28 Sept 2012 | OTHER | PAR PHARMACEUTICAL COMPANIES, INC. | 10,000 | 1.25 USD | deriv |
| 28 Sept 2012 | OTHER | PAR PHARMACEUTICAL COMPANIES, INC. | 5,000 | 7.86 USD | deriv |
| 28 Sept 2012 | OTHER | PAR PHARMACEUTICAL COMPANIES, INC. | 5,000 | 16.38 USD | deriv |
| 28 Sept 2012 | OTHER | PAR PHARMACEUTICAL COMPANIES, INC. | 5,000 | 23.62 USD | deriv |
| 02 Jul 2012 | GRANT_AWARD | PAR PHARMACEUTICAL COMPANIES, INC. | 651 | 36.50 USD | deriv |
| 02 Apr 2012 | GRANT_AWARD | PAR PHARMACEUTICAL COMPANIES, INC. | 597 | 39.80 USD | deriv |
| 19 Mar 2012 | EXERCISE | PAR PHARMACEUTICAL COMPANIES, INC. | 7,500 | 28.79 USD | |
| 19 Mar 2012 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 2,940 | 37.01 USD | |
| 19 Mar 2012 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 507 | 37.02 USD | |
| 19 Mar 2012 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 207 | 37.03 USD | |
| 19 Mar 2012 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 1,803 | 37.04 USD | |
| 19 Mar 2012 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 1,203 | 37.05 USD | |
| 19 Mar 2012 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 304 | 37.06 USD | |
| 19 Mar 2012 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 300 | 37.07 USD | |
| 19 Mar 2012 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 136 | 37.08 USD | |
| 19 Mar 2012 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 100 | 37.09 USD | |
| 19 Mar 2012 | EXERCISE | PAR PHARMACEUTICAL COMPANIES, INC. | 7,500 | 0.00 USD | deriv |
| 05 Jan 2012 | GRANT_AWARD | PAR PHARMACEUTICAL COMPANIES, INC. | 3,816 | 0.00 USD | deriv |
| 03 Jan 2012 | GRANT_AWARD | PAR PHARMACEUTICAL COMPANIES, INC. | 732 | 32.45 USD | deriv |
| 15 Dec 2011 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 200 | 32.50 USD | |
| 15 Dec 2011 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 2,200 | 32.50 USD | |